Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases.

CONCLUSIONS: In half cases, it was decided to stop biologic therapy in the family planning period. Using biologic disease-modifying anti-rheumatic drugs before and/or during pregnancy doesn't seem to affect the overall maternal and fetal outcomes. Pregnancy planning and treatment options should be discussed and a shared decision should be established between physician and patient.
PMID: 32008032 [PubMed - as supplied by publisher]

Source: Acta Reumatologica Portuguesa - December 25, 2019 Category: Rheumatology Authors: Brites L, Madeira N, Rodrigues J, Marona J, Martins N, Águeda A, Freitas R, Neto A, Capela S, Sequeira G, Ganhão S, Duarte C, Santiago M, Santos MJ Tags: Acta Reumatol Port Source Type: research